V. Theobald

发表

Drug Target Interference in Immunogenicity Assays: Recommendations and Mitigation Strategies

Yuling Wu, B. Gorovits, M. Maia, 2017, The AAPS Journal.

Immunogenicity Testing Using Flow Cytometry

Denise M O'Hara, V. Theobald, 2010 .

Validation of a HLA-A2 tetramer flow cytometric method, IFNgamma real time RT-PCR, and IFNgamma ELISPOT for detection of immunologic response to gp100 and MelanA/MART-1 in melanoma patients

M. Perricone, S. Richards, Yuanxin Xu, 2008, Journal of Translational Medicine.

“NEUTRAL ALLOGRAFTS”‐LACK OF ALLOGENEIC STIMULATION BY CULTURED HUMAN CELLS EXPRESSING MHC CLASS I AND CLASS II ANTIGENS

V. Theobald, M. Rosenberg, J. Lauer, 1993, Transplantation.

Ligand Binding Assays in the 21st Century Laboratory: Recommendations for Characterization and Supply of Critical Reagents

Afshin Safavi, Valerie Theobald, Denise M O'Hara, 2012, The AAPS Journal.

Ligand Binding Assays in the 21st Century Laboratory: Recommendations for Characterization and Supply of Critical Reagents

Denise M O'Hara, Adrienne Clements Egan, J. Terwee, 2012, The AAPS Journal.

Next Generation Ligand Binding Assays—Review of Emerging Technologies’ Capabilities to Enhance Throughput and Multiplexing

Mark Dysinger, Karolina Österlund, J. Mora, 2014, The AAPS Journal.

A breakthrough novel method to resolve the drug and target interference problem in immunogenicity assays.

Susan Richards, Jad Zoghbi, Valerie Theobald, 2015, Journal of immunological methods.

Life cycle management of critical ligand-binding reagents.

Valerie Theobald, Denise M O'Hara, V. Theobald, 2013, Bioanalysis.

2013 White Paper on recent issues in bioanalysis: 'hybrid'--the best of LBA and LCMS.

Stacy Ho, Roger Hayes, Eric Woolf, 2013, Bioanalysis.

Validation of a HLA-A2 tetramer flow cytometric method, IFNgamma real time RT-PCR, and IFNgamma ELISPOT for detection of immunologic response to gp100 and MelanA/MART-1 in melanoma patients

M. Perricone, S. Richards, Yuanxin Xu, 2008, Journal of Translational Medicine.